爱科诺生物医药完成近亿元B+轮融资
爱科诺生物医药有限公司完成近亿元B+轮融资，由深创投领投，晨兴创投、领军创投和合肥创新投跟投。资金将用于推进炎症性肠病、银屑病等炎症与自身免疫疾病药物的临床开发。
媒体报道
「最新融资」爱科诺生物：完成近亿元B+轮融资，加速多个针对炎症及自身免疫性疾病候选药物的研发进程 医药魔方
爱科诺生物医药完成近亿元B+轮融资 界面
爱科诺生物医药完成近亿元B+轮融资，加速多个针对炎症及自身免疫性疾病候选药物的研发进程 医药魔方
#热门话题
BY Readhub
Tata Power whose core business is to generate, transmit and distribute electricity has made no money to investors in the last one decade. That is a big blunder considering it is one of the largest power generation companies in the country. One of the reasons is the company's huge debt levels which stood at ₹43,559 crore at the end of March 2021 compared to the company’s market capitalisation of ₹44,447 crore.
To pay the bills, Mr. Durov is issuing investors $1 billion to $1.5 billion of company debt, with the promise of discounted equity if the company eventually goes public, the people briefed on the plans said. He has also announced plans to start selling ads in public Telegram channels as soon as later this year, as well as offering other premium services for businesses and users.
Readhub from sg